SCHEMBL7971695

SCHEMBL7971695

O=C1NC(=S)SC1=Cc1ccc(OCc2cccc3ccccc23)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP13 P45452 3/20 0.69
MMP3 P08254 2/20 0.69
SIRT2 Q8IXJ6 1/20 0.68
CTSD P07339 2/20 0.59
MGAM O43451 1/20 0.58
GAA P10253 1/20 0.58
SI P14410 1/20 0.58
MGAM2 Q2M2H8 1/20 0.58
PTGS2 P35354 2/20 0.57
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
PIM1 P11309 2/20 0.57
POLB P06746 2/20 0.57
BLM P54132 1/20 0.57
NOD2 Q9HC29 1/20 0.57
RAB9A P51151 1/20 0.57
ADAMTS5 Q9UNA0 2/20 0.56
GSK3B P49841 1/20 0.55
CSNK2A2 P19784 1/20 0.55
CLK1 P49759 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7971693 1.00 MMP13 (0.69) MMP13MMP3SIRT2CTSDMGAM
SCHEMBL12892051 0.89 ADAMTS5 (0.72) MMP13MMP3CTSDMGAMGAA
SCHEMBL7958747 0.84 MMP3 (0.71) MMP13MMP3CTSDMGAMGAA
SCHEMBL7958745 0.84 MMP3 (0.71) MMP13MMP3CTSDMGAMGAA
SCHEMBL7968308 0.84 MMP3 (0.71) MMP13MMP3CTSDMGAMGAA
SCHEMBL7971523 0.84 MMP3 (0.71) MMP13MMP3CTSDMGAMGAA
SCHEMBL7969940 0.84 MMP3 (0.71) MMP13MMP3CTSDMGAMGAA
SCHEMBL7969943 0.84 MMP3 (0.71) MMP13MMP3CTSDMGAMGAA
SCHEMBL7968305 0.84 MMP3 (0.71) MMP13MMP3CTSDMGAMGAA
SCHEMBL7971526 0.84 MMP3 (0.71) MMP13MMP3CTSDMGAMGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6251928-B1 ADMINISTERING BENZYLIDENE RHODANINES WHICH ARE USEFUL AS AGENTS IN TREATING OR PREVENTING CONDITIONS ASSOCIATED WITH BETA-AMYLOID PEPTIDE IN A MAMMAL ELI LILLY AND COMPANY 2001-06-26 US disclosed
EP-0677517-A1 Treatment of Alzheimer's disease employing inhibitors of cathepsin D ELI LILLY AND COMPANY (US) 1995-10-18 EP disclosed